Novel method and compositions

Details for Australian Patent Application No. 2008223951 (hide)

Owner GlaxoSmithKline Biologicals S.A.

Inventors Voss, Gerald Hermann

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008223951

PCT Pub. Number WO2008/107370

Priority 60/892,714 02.03.07 US

Filing date 28 February 2008

Wipo publication date 12 September 2008

International Classifications

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 14/445 (2006.01) Peptides having more than 20 amino acids

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

Event Publications

1 October 2009 PCT application entered the National Phase

  PCT publication WO2008/107370 Priority application(s): WO2008/107370

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008223952-Method for providing a fouling preventing coating

2008223947-Module for manufacturing electric volatile substance evaporators